NMR-based metabonomic evaluation of livers from rats chronically treated with tamoxifen, mestranol, and phenobarbital

In this study, we look at the metabolic effects of long-term dosing with tamoxifen, mestranol or phenobarbital on the liver. Tamoxifen, mestranol and phenobarbital have all been reported to act as promoters of hepatic tumors. While tamoxifen and mestranol are known to have estrogenic activity, in the liver phenobarbital is a non-estrogenic compound. Aqueous and lipophilic liver extracts from control and chronically treated Fisher 344 rats were evaluated by nuclear magnetic resonance spectroscopy (NMR). In both the aqueous and lipophilic sample sets, the estrogenic action of mestranol appears to be responsible for the clustering of these samples with those animals treated with tamoxifen. Phenobarbital does not have estrogenic activity and, therefore, clusters away from the estrogenic and control groups. In the lipophilic samples, the fatty acid peak (CH2)n was higher in tamoxifen-treated rats than in control, phenobarbital- or mestranol-treated rats. In the aqueous samples, serine and choline levels were higher in phenobarbital-treated rats than controls, which may be an indication that the folate–homocysteine metabolic pathways were altered.

[1]  B. Furr,et al.  The pharmacology and clinical uses of tamoxifen. , 1984, Pharmacology & therapeutics.

[2]  Y. Dragan,et al.  Studies of tamoxifen as a promoter of hepatocarcinogenesis in female Fischer F344 rats , 2004, Breast Cancer Research and Treatment.

[3]  Henrik Antti,et al.  Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project. , 2003, Toxicology and applied pharmacology.

[4]  V. Jordan,et al.  Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration. , 1988, Cancer research.

[5]  H. Taper.  The effect of estradiol‐17‐phenylpropionate and estradiol benzoate on N‐nitrosomorpholine‐induced liver carcinogenesis in ovariectomized female rats , 1978, Cancer.

[6]  G. Boers,et al.  Neural-tube defects and derangement of homocysteine metabolism. , 1991, The New England journal of medicine.

[7]  V. Jordan,et al.  Endocrine pharmacology of antiestrogens as antitumor agents. , 1990, Endocrine reviews.

[8]  J. Nicholson,et al.  Application of biofluid 1H nuclear magnetic resonance-based metabonomic techniques for the analysis of the biochemical effects of dietary isoflavones on human plasma profile. , 2003, Analytical biochemistry.

[9]  P J Sadler,et al.  Proton-nuclear-magnetic-resonance studies of serum, plasma and urine from fasting normal and diabetic subjects. , 1984, The Biochemical journal.

[10]  V. Jordan,et al.  Long-term adjuvant tamoxifen therapy for breast cancer , 1990, Breast Cancer Research and Treatment.

[11]  Shih-Png Ye,et al.  Stimulation of hepatocyte DNA synthesis by ethinyl estradiol. , 1991, Progress in clinical and biological research.

[12]  M. Reily,et al.  Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[13]  S. Fuqua,et al.  Molecular aspects of estrogen receptor variants in breast cancer , 1995, Breast Cancer Research and Treatment.

[14]  D. Cory,et al.  Gradient, high‐resolution, magic‐angle spinning nuclear magnetic resonance spectroscopy of human adipocyte tissue , 1997, Magnetic resonance in medicine.

[15]  E Holmes,et al.  NMR spectroscopy based metabonomic studies on the comparative biochemistry of the kidney and urine of the bank vole (Clethrionomys glareolus), wood mouse (Apodemus sylvaticus), white toothed shrew (Crocidura suaveolens) and the laboratory rat. , 2000, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[16]  S. Hilsenbeck,et al.  The importance of tamoxifen metabolism in tamoxifen-stimulated breast tumor growth , 2004, Cancer Chemotherapy and Pharmacology.

[17]  A. Parkinson,et al.  Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation. , 1993, Drug metabolism and disposition: the biological fate of chemicals.

[18]  T. Orton,et al.  Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats. , 1993, Cancer research.

[19]  J. Griffin,et al.  Cellular environment of metabolites and a metabonomic study of tamoxifen in endometrial cells using gradient high resolution magic angle spinning 1H NMR spectroscopy. , 2003, Biochimica et biophysica acta.

[20]  C. Jefcoate,et al.  The induction of five rat hepatic P450 cytochromes by phenobarbital and similarly acting compounds is regulated by a sexually dimorphic, dietary-dependent endocrine factor that is highly strain specific. , 1994, Archives of biochemistry and biophysics.

[21]  A. R. Tate,et al.  Distinction between normal and renal cell carcinoma kidney cortical biopsy samples using pattern recognition of 1H magic angle spinning (MAS) NMR spectra , 2000, NMR in biomedicine.

[22]  W. Backes,et al.  Pituitary component of the aromatic hydrocarbon-mediated expression of CYP2B and CYP2C11. , 1998, Xenobiotica; the fate of foreign compounds in biological systems.

[23]  J. Lindon,et al.  'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[24]  E. Schuetz,et al.  Differentiated induction of cytochrome P450b/e and P450p mRNAs by dose of phenobarbital in primary cultures of adult rat hepatocytes. , 1990, Molecular pharmacology.

[25]  L. Poirier.  The effects of diet, genetics and chemicals on toxicity and aberrant DNA methylation: an introduction. , 2002, The Journal of nutrition.

[26]  C. Jefcoate,et al.  Phenobarbital induction of CYP2B1/2 in primary hepatocytes: endocrine regulation and evidence for a single pathway for multiple inducers. , 1999, Toxicology and applied pharmacology.

[27]  Royston Goodacre,et al.  Application of high-throughput Fourier-transform infrared spectroscopy in toxicology studies: contribution to a study on the development of an animal model for idiosyncratic toxicity. , 2004, Toxicology letters.

[28]  V. Jordan,et al.  Pharmacology of tamoxifen in laboratory animals. , 1980, Cancer treatment reports.

[29]  Jianghua Feng,et al.  1H NMR analysis for metabolites in serum and urine from rats administrated chronically with La(NO3)3. , 2002, Analytical biochemistry.

[30]  D. DeMets,et al.  Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer. , 1990, Journal of the National Cancer Institute.

[31]  Robert S Plumb,et al.  Metabonomics: the use of electrospray mass spectrometry coupled to reversed-phase liquid chromatography shows potential for the screening of rat urine in drug development. , 2002, Rapid communications in mass spectrometry : RCM.

[32]  M. Stampfer,et al.  Epidemiology of vascular and thrombotic associations , 2001 .

[33]  R. Gonzalez,et al.  Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[34]  V. Jordan,et al.  Metabolites of tamoxifen in animals and man: Identification, pharmacology, and significance , 1982, Breast cancer research and treatment.

[35]  Ian D. Wilson,et al.  HIGH RESOLUTION PROTON MAGNETIC RESONANCE SPECTROSCOPY OF BIOLOGICAL FLUIDS , 1989 .

[36]  P. Beaune,et al.  Identification of the cytochrome P450 IIIA family as the enzymes involved in the N-demethylation of tamoxifen in human liver microsomes. , 1991, Biochemical pharmacology.

[37]  M. Spraul,et al.  High resolution magic angle spinning 1H nuclear magnetic resonance analysis of intact prostatic hyperplastic and tumour tissues , 1998 .

[38]  A. Parkinson,et al.  Involvement of cytochrome P4503A in catalysis of tamoxifen activation and covalent binding to rat and human liver microsomes. , 1994, Carcinogenesis.

[39]  J. Nicholson,et al.  Abnormal lipid profile of dystrophic cardiac tissue as demonstrated by one‐ and two‐dimensional magic‐angle spinning 1H NMR spectroscopy , 2001, Magnetic resonance in medicine.

[40]  H. Bolt,et al.  Demethylation of mestranol to ethinyloestradiol in vitro and in vivo. , 1972, Acta endocrinologica.

[41]  I. Wilson,et al.  High resolution nuclear magnetic resonance spectroscopy of biological samples as an aid to drug development. , 1987, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[42]  Y. Dragan,et al.  Effect of the separate and combined administration of mestranol and phenobarbital on the development of altered hepatic foci expressing placental form of glutathione S-transferase in the rat. , 1996, Carcinogenesis.

[43]  S. Mishkin,et al.  Evidence for the Hormone Dependency of Hepatic Hyperplastic Nodules: Inhibition of Malignant Transformation After Exogenous 17β‐Estradiol and Tamoxifen , 2007, Hepatology.

[44]  John C. Lindon,et al.  NMR Spectroscopy of Biofluids , 1999 .

[45]  M. Baum,et al.  Alternative mechanisms of action of anti-oestrogens , 2004, Breast Cancer Research and Treatment.

[46]  S. Robinson,et al.  Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse. , 1988, Cancer research.

[47]  H. Pitot,et al.  Comparison of the effects of tamoxifen and toremifene on liver and kidney tumor promotion in female rats. , 1995, Carcinogenesis.

[48]  R. Schulte‐Hermann,et al.  Effect of tumor promoting contraceptive steroids on growth and drug metabolizing enzymes in rat liver. , 1986, Cancer research.

[49]  J. Nicholson,et al.  High‐resolution 1H NMR and magic angle spinning NMR spectroscopic investigation of the biochemical effects of 2‐bromoethanamine in intact renal and hepatic tissue , 2001, Magnetic resonance in medicine.

[50]  M. Ahotupa,et al.  Tamoxifen induces hepatocellular carcinoma in rat liver , 1990 .

[51]  M. Spraul,et al.  Direct observation of resolved intracellular and extracellular water signals in intact human red blood cells using 1H MAS NMR spectroscopy , 1997, Magnetic resonance in medicine.

[52]  A. Medline,et al.  Role of estrogens as promoters of hepatic neoplasia. , 1982, Laboratory investigation; a journal of technical methods and pathology.

[53]  M. Spraul,et al.  750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. , 1995, Analytical chemistry.

[54]  V. Jordan,et al.  Tamoxifen: toxicities and drug resistance during the treatment and prevention of breast cancer. , 1995, Annual review of pharmacology and toxicology.

[55]  C. Jefcoate,et al.  Endocrine factors modulate the phenobarbital-mediated induction of cytochromes P450 and phase II enzymes in a similar strain-dependent manner. , 1998, Toxicology and applied pharmacology.

[56]  E Holmes,et al.  Development of a model for classification of toxin‐induced lesions using 1H NMR spectroscopy of urine combined with pattern recognition , 1998, NMR in biomedicine.

[57]  R. E. Peterson,et al.  Effects of Ethinylestradiol-Induced Cholestasis on Bile Flow and Biliary Excretion of Estradiol and Estradiol Glucuronide by the Rat∗ , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[58]  V. Jordan,et al.  Effect of steroidal and nonsteroidal antiestrogens on the growth of a tamoxifen-stimulated human endometrial carcinoma (EnCa101) in athymic mice. , 1990, Cancer research.

[59]  J. Lindon,et al.  Metabonomics: a platform for studying drug toxicity and gene function , 2002, Nature Reviews Drug Discovery.

[60]  K. Mccully.  Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. , 1969, The American journal of pathology.

[61]  O. Fiehn.  Metabolomics – the link between genotypes and phenotypes , 2004, Plant Molecular Biology.

[62]  Anthony F. P. Nash,et al.  A 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects. , 2003, Journal of pharmaceutical and biomedical analysis.

[63]  T. Ebbels,et al.  Analytical reproducibility in (1)H NMR-based metabonomic urinalysis. , 2002, Chemical research in toxicology.

[64]  D. Kell,et al.  Metabolic profiling using direct infusion electrospray ionisation mass spectrometry for the characterisation of olive oils. , 2002, The Analyst.

[65]  E Holmes,et al.  NMR and pattern recognition studies on the time-related metabolic effects of alpha-naphthylisothiocyanate on liver, urine, and plasma in the rat: an integrative metabonomic approach. , 2001, Chemical research in toxicology.

[66]  V. Jordan,et al.  Tamoxifen‐stimulated Growth of Human Endometrial Carcinoma , 1991, Annals of the New York Academy of Sciences.

[67]  E Holmes,et al.  High‐resolution magic angle spinning 1H NMR spectroscopic studies on intact rat renal cortex and medulla , 1999, Magnetic resonance in medicine.

[68]  I. Wilson,et al.  Understanding 'Global' Systems Biology: Metabonomics and the Continuum of Metabolism , 2003, Nature Reviews Drug Discovery.

[69]  G. Lucier,et al.  Growth stimulation followed by growth inhibition in livers of female rats treated with ethinyl estradiol. , 1994, Carcinogenesis.

[70]  J. Yager,et al.  Effects of ethinyl estradiol and tamoxifen on liver DNA turnover and new synthesis and appearance of gamma glutamyl transpeptidase-positive foci in female rats. , 1986, Carcinogenesis.

[71]  I. White,et al.  Induction of CYP2B1 and 3A1, and associated monoxygenase activities by tamoxifen and certain analogues in the livers of female rats and mice. , 1993, Biochemical pharmacology.

[72]  J. Yager,et al.  Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats. , 1980, Cancer research.

[73]  J C Lindon,et al.  Biochemical classification of kidney carcinoma biopsy samples using magic-angle-spinning 1H nuclear magnetic resonance spectroscopy. , 1998, Journal of pharmaceutical and biomedical analysis.

[74]  C. Omiecinski,et al.  Developmental expression and in situ localization of the phenobarbital-inducible rat hepatic mRNAs for cytochromes CYP2B1, CYP2B2, CYP2C6, and CYP3A1. , 1990, Molecular pharmacology.

[75]  H C Pitot,et al.  Phase II enzyme expression in rat liver in response to the antiestrogen tamoxifen. , 1996, Cancer research.

[76]  C. Wolf,et al.  Species differences in the covalent binding of [14C]tamoxifen to liver microsomes and the forms of cytochrome P450 involved. , 1995, Biochemical pharmacology.

[77]  B. Henderson,et al.  Regression of liver cell adenomas associated with oral contraceptives. , 1977, Annals of internal medicine.

[78]  Y. Dragan,et al.  Effects of tamoxifen administration on the expression of xenobiotic metabolizing enzymes in rat liver. , 1995, Cancer research.

[79]  R. Gebhardt,et al.  Non-linearity of neoplastic conversion induced in rat liver by low exposures to diethylnitrosamine. , 1993, Carcinogenesis.

[80]  G. Williams,et al.  The triphenylethylene drug tamoxifen is a strong liver carcinogen in the rat. , 1993, Carcinogenesis.